FR09C0022I2 - - Google Patents
Info
- Publication number
- FR09C0022I2 FR09C0022I2 FR09C0022C FR09C0022C FR09C0022I2 FR 09C0022 I2 FR09C0022 I2 FR 09C0022I2 FR 09C0022 C FR09C0022 C FR 09C0022C FR 09C0022 C FR09C0022 C FR 09C0022C FR 09C0022 I2 FR09C0022 I2 FR 09C0022I2
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3282096P | 1996-12-11 | 1996-12-11 | |
| US08/886,933 US6071904A (en) | 1996-12-11 | 1997-07-02 | Process for manufacturing ophthalmic suspensions |
| PCT/US1997/015727 WO1998025620A1 (en) | 1996-12-11 | 1997-09-05 | Process for manufacturing ophthalmic suspensions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR09C0022I1 FR09C0022I1 (id) | 2009-09-25 |
| FR09C0022I2 true FR09C0022I2 (id) | 2010-06-11 |
Family
ID=26708929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR09C0022C Active FR09C0022I2 (id) | 1996-12-11 | 2009-05-25 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6071904A (id) |
| EP (1) | EP0941094B1 (id) |
| JP (1) | JP3611863B2 (id) |
| AT (1) | ATE209917T1 (id) |
| CA (1) | CA2274680C (id) |
| DE (2) | DE69708912T2 (id) |
| DK (1) | DK0941094T3 (id) |
| ES (1) | ES2169416T3 (id) |
| FR (1) | FR09C0022I2 (id) |
| HK (1) | HK1019704A1 (id) |
| LU (1) | LU91554I2 (id) |
| NL (1) | NL300388I2 (id) |
| PT (1) | PT941094E (id) |
| WO (1) | WO1998025620A1 (id) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000001365A1 (en) * | 1998-06-30 | 2000-01-13 | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) | Prolonged release ophthalmic compositions containing a fluoroquinolone |
| DK1392355T3 (da) | 2001-05-21 | 2007-04-30 | Alcon Inc | Anvendelse af proteasominhibitorer tilbehandling af öjentörhedslidelser |
| PL367286A1 (en) | 2001-05-21 | 2005-02-21 | Alcon, Inc. | Use of nfkb inhibitors to treat dry eye disorders |
| US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
| US7112588B2 (en) * | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
| JP2004531560A (ja) * | 2001-05-21 | 2004-10-14 | アルコン，インコーポレイテッド | ドライアイ障害を処置する方法 |
| TWI298257B (en) | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
| US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
| DE60313299T2 (de) * | 2002-03-01 | 2008-01-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Selbstemulgierende systeme zur abgabe von taxoiden |
| ATE393627T1 (de) | 2003-01-21 | 2008-05-15 | Senju Pharma Co | Wässrige flüssige zubereitung mit 2-amino-3-(4- bromobenzoyl)phenylessigsäure |
| ATE497787T1 (de) * | 2004-03-12 | 2011-02-15 | Cipla Ltd | Sterilisationsprozess für steroide |
| WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
| PL1891939T3 (pl) * | 2006-07-28 | 2014-01-31 | Santen Sas | Kompozycje zawierające czwartorzędowe związki amonowe |
| TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
| TWI489997B (zh) | 2009-06-19 | 2015-07-01 | Alcon Res Ltd | 含有硼酸－多元醇錯合物之水性藥學組成物 |
| AU2010325632B2 (en) * | 2009-12-03 | 2014-01-30 | Lupin Limited | Process for preparing pharmaceutical ophthalmic compositions |
| EP2394637A1 (en) * | 2010-05-21 | 2011-12-14 | Zaklady Farmaceutyczne Polpharma SA | Process for obtaining sterile brinzolamide suspensions |
| KR101820184B1 (ko) | 2010-07-29 | 2018-01-18 | 알러간, 인코포레이티드 | 방부제가 없는 비마토프로스트 및 티몰롤 용액 |
| US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
| WO2012053011A2 (en) | 2010-10-18 | 2012-04-26 | Usv Limited | Ophthalmic compositions comprising brinzolamide |
| US20130065888A1 (en) | 2011-08-15 | 2013-03-14 | Biserka Cetina-Cizmek | Ophthalmic formulations and processes for their preparation |
| EP2638909A1 (en) | 2012-03-15 | 2013-09-18 | Azad Pharmaceutical Ingredients AG | Process for preparing sterile Brinzolamide |
| GR1007906B (el) * | 2012-03-22 | 2013-05-30 | Φαρματεν Αβεε, | Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου |
| PT2846845T (pt) | 2012-05-09 | 2017-06-02 | Icrom Spa | Produção de brinzolamida farmacêutica estéril |
| US20150119386A1 (en) * | 2012-05-21 | 2015-04-30 | Aurobindo Pharma Limited | Process for preparing opthalmic suspension of brinzolamide |
| WO2014057499A1 (en) | 2012-10-11 | 2014-04-17 | Indoco Remedies Limited | A process for manufacturing sterile brinzolamide ophthalmic suspension |
| CN104721136A (zh) * | 2013-02-21 | 2015-06-24 | 四川大学 | 一种布佐林胺眼用纳米混悬剂及其制备方法 |
| EA030535B1 (ru) * | 2013-10-17 | 2018-08-31 | Сентисс Фарма Прайвет Лимитед | Не содержащий консерванта офтальмологический фармацевтический состав |
| US9820991B2 (en) * | 2013-11-08 | 2017-11-21 | Sentiss Pharma Private Limited | Pharmaceutical composition comprising brinzolamide |
| WO2015068105A1 (en) | 2013-11-08 | 2015-05-14 | Sentiss Pharma Private Limited | An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions |
| EP3096740B1 (en) * | 2014-01-24 | 2020-09-30 | Sentiss Pharma Private Limited | Pharmaceutical composition comprising brinzolamide |
| PL407710A1 (pl) * | 2014-03-28 | 2015-10-12 | Instytut Farmaceutyczny | Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem |
| JP6279395B2 (ja) * | 2014-05-01 | 2018-02-14 | 東亜薬品株式会社 | ブリンゾラミド懸濁性点眼液組成物の製造方法 |
| US11285163B2 (en) | 2014-10-20 | 2022-03-29 | Sentiss Pharma Private Limited | Ophthalmic solution |
| TWI664965B (zh) | 2015-06-22 | 2019-07-11 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法 |
| CN107582519A (zh) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | 一种布林佐胺滴眼液制剂及其制备方法 |
| GR1009419B (el) | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
| AU2019259343B2 (en) | 2018-04-25 | 2022-02-17 | Shilpa Medicare Limited | Ophthalmic compositions of brinzolamide |
| GR1009616B (el) * | 2018-07-20 | 2019-10-11 | Φαρματεν Α.Β.Ε.Ε. | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου |
| WO2020240451A1 (en) | 2019-05-29 | 2020-12-03 | Lupin Limited | In-situ gelling nanoemulsion of brinzolamide |
| US11850249B2 (en) | 2020-10-05 | 2023-12-26 | Somerset Therapeutics, Llc | Methods of efficiently reducing intraocular pressure |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
| WO1992018124A1 (en) * | 1991-04-17 | 1992-10-29 | Merck & Co., Inc. | OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST |
| DE69320329T2 (de) * | 1992-02-21 | 1998-12-24 | Alcon Laboratories, Inc., Fort Worth, Tex. | Topische Antiglaukoma Zusammensetzungen, enthaltend Karbonhydrasehemmer und Beta-Blocker |
| US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
| US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| US5429824A (en) * | 1992-12-15 | 1995-07-04 | Eastman Kodak Company | Use of tyloxapole as a nanoparticle stabilizer and dispersant |
| US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
-
1997
- 1997-07-02 US US08/886,933 patent/US6071904A/en not_active Expired - Lifetime
- 1997-09-05 ES ES97939835T patent/ES2169416T3/es not_active Expired - Lifetime
- 1997-09-05 DE DE69708912T patent/DE69708912T2/de not_active Expired - Lifetime
- 1997-09-05 PT PT97939835T patent/PT941094E/pt unknown
- 1997-09-05 CA CA002274680A patent/CA2274680C/en not_active Expired - Lifetime
- 1997-09-05 AT AT97939835T patent/ATE209917T1/de active
- 1997-09-05 DK DK97939835T patent/DK0941094T3/da active
- 1997-09-05 WO PCT/US1997/015727 patent/WO1998025620A1/en active IP Right Grant
- 1997-09-05 EP EP97939835A patent/EP0941094B1/en not_active Expired - Lifetime
- 1997-09-05 JP JP52598698A patent/JP3611863B2/ja not_active Expired - Lifetime
- 1997-09-05 DE DE122009000016C patent/DE122009000016I1/de active Pending
-
1999
- 1999-10-23 HK HK99104734A patent/HK1019704A1/xx not_active IP Right Cessation
-
2009
- 2009-04-22 LU LU91554C patent/LU91554I2/fr unknown
- 2009-05-11 NL NL300388C patent/NL300388I2/nl unknown
- 2009-05-25 FR FR09C0022C patent/FR09C0022I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU718079B2 (en) | 2000-04-06 |
| DE122009000016I1 (de) | 2009-06-25 |
| NL300388I1 (nl) | 2009-07-01 |
| AU4183897A (en) | 1998-07-03 |
| NL300388I2 (nl) | 2010-02-01 |
| DE69708912D1 (de) | 2002-01-17 |
| EP0941094A1 (en) | 1999-09-15 |
| EP0941094B1 (en) | 2001-12-05 |
| DE69708912T2 (de) | 2002-04-11 |
| ES2169416T3 (es) | 2002-07-01 |
| US6071904A (en) | 2000-06-06 |
| JP2000501749A (ja) | 2000-02-15 |
| HK1019704A1 (en) | 2000-02-25 |
| ATE209917T1 (de) | 2001-12-15 |
| CA2274680A1 (en) | 1998-06-18 |
| CA2274680C (en) | 2003-11-18 |
| JP3611863B2 (ja) | 2005-01-19 |
| DK0941094T3 (da) | 2002-01-07 |
| WO1998025620A1 (en) | 1998-06-18 |
| FR09C0022I1 (id) | 2009-09-25 |
| PT941094E (pt) | 2002-05-31 |
| LU91554I2 (fr) | 2009-06-22 |